MAPRE2 and craniodiaphyseal dysplasia: Perhaps the icing on the cake, however, is the demonstration that endogenous EB2 phosphorylation (as judged by a phospho‐specific EB2 antibody able to recognise an identical phospho‐epitope in human and mouse EB2) is severely reduced (by ~80%) in neurons derived from CDD patient fibroblasts after reprogramming into iSPCs (Baltussen et al, 2018).